medigraphic.com
ISSN 0185-3325 (Print)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz

2013, Number 2

<< Back Next >>

Salud Mental 2013; 36 (2)

El problema del consumo de cannabis: el papel del Sector Salud

del Bosque J, Fernández C, Sánchez HR, Díaz DB, Gutiérrez LAD, Fuentes MA, Espínola M, González GN, Loredo AA, Medina-Mora ME, Alvarado RN, Natera G, Real T, Sansores R, Prospéro-García O, Zinser J, Suárez C, Beltrán A

Language: Spanish
References: 55
Page: 149-158
PDF size: 257.28 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Babor T, Miller P, Edwards G. Vested interests, addiction research and public policy. Addiction 2010;105(1):4-5.

  2. National Institute on Drug Abuse (NIDA). Abuso de la marihuana. Disponible en línea: http://www.nida.nih.gov/ResearchReports/Marihuana/ default.html (recuperado en 2011).

  3. Méndez M, Ruiz AE, Prieto B, Romano A et al. El cerebro y las drogas, sus mecanismos neurobiológicos. Salud Mental 2010;33:451-456.

  4. Cravatt DF, Prospéro-García O, Siuzdak G, Gilula NB, et al. Chemical characterization of a family of brain lipids that induce sleep. Science 1995;268:1506-1509.

  5. Di Marzo V, Bifulco M, De Petrocellis L. The endocannabinoid system and its therapeutic exploitation. Nature Rev. Drug Discovery 2004:3:771-784.

  6. Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology Reviews 2010;35:217-238.

  7. Ruiz AE, Méndez M, Prieto Gómez B, Romano A et al. El cerebro, las drogas y los genes. Salud Mental 2010;33:535-542.

  8. Dumontheil I, Burgess PW, Blakemore S-J. Development of rostral prefrontal cortex and cognitive and behavioral disorders. Dev Med Child Neurol 2008;50:168-181.

  9. Benjet C, Borges G, Méndez E, Fleiz C, Medina-Mora ME. The association of chronic adversity with psychiatric disorder and disorder severity in adolescents. Eur Child Adolesc Psychiatry 2011;20(9):459-468.

  10. Fergusson D, Boden J, Horwood L. Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction 2006;101(4):556-569.

  11. Fergusson D , Boden J, Horwood L. The developmental antecedents of illicit drug use: Evidence from a 25-year longitudinal study. Drug Alcohol Depend 2008;96(1-2): 165-177.

  12. Arellanez J, Diaz D Wagner F, Pérez V. Factores psicosociales asociados con el abuso y la dependencia de drogas entre adolescentes: Análisis bivariados de un estudio de casos y controles. Salud Mental 2004;27(3):54-64.

  13. Rodríguez S, Diaz B, Gracia S, Guerrero A. Capacidad predictiva de la Teoría de la Conducta Planificada en la intención y uso de drogas ilícitas entre estudiantes mexicanos. Salud Mental 2007;30(1):68-81.

  14. Newman K, Harrison L, Dashiff C, Davies S. Relationships between parenting styles and risk behaviors in adolescent health: an integrative literature review. Rev Lat Am Enfermagem 2008;16(1):142-150.

  15. Lloyd DA, Turner RJ. Cumulative life-time adversities and alcohol dependence in adolescence and young adulthood. Drug Alcohol Depend 2008;93:217–226.

  16. Sartor C, Lynskey M, Bucholz K, McCutcheon V et al. Childhood sexual abuse and the course of alcohol dependence development: Findings from a female twin sample. Heath Drug Alcohol Depend 2007;89(2-3):139–144.

  17. Kwok-Kei Mak, Sai-Yin Ho, Neil Thomas G, Schooling CM et al. Family structure, parent-child conversation time and substance use among Chinese adolescents. BMC Public Health 2010;10:503.

  18. Lynskey M, Vink J, Boomsma D. Early onset cannabis use and progression to other drug use in a sample of Dutch twins, Behavior Genetics 2006;36(2):195-200.

  19. Russell K, Dryden DM, Yuanyuan Liang, Friesen C et al. Risk factors for methamphetamine use in youth: a systematic review. BMC Pediatrics 2008;8:48 doi:10.1186/1471-2431-8-48.

  20. Bretteville-Jensen A, Melberg H, Jones A. Sequential patterns of drug use initiation, Can we relieve in the gateway theory? BE J Econom Analysis Policy 2008;8(2): 1846-1846.

  21. Wu B, Mao ZF, Rockett IR, Yue Y. Socioeconomic status and alcohol use among urban and rural residents in China. Subst Use Misuse 2008;43(7):952-966.

  22. Chuan-Yu Chen, Storr C, Anthony J. Early-onset drug use and risk for drug dependence problems. Addict Behav 2009;34(3):319–322.

  23. McLaughlin K, Greif Green J, Gruber M, Sampson N et al. Childhood adversities and adult psychopathology in the National Comorbidity Survey Replication (NCS-R) II: Associations with persistence of DSM-IV disorders. Arch Gen Psychiatry 2010;67(2):124–132.

  24. Diaz N, Arellanez J, Martínez J. Uso de drogas y factores psicosociales asociados entre estudiantes de educación media básica del estado de Nuevo León. En: Secretaría de Salud, CONADIC. Observatorio mexicano en tabaco, alcohol y otras drogas. México: SSA, CONADIC. 2002; pp. 133-136.

  25. Diaz N, García R. Factores psicosociales de riesgo de consumo de drogas ilícitas en una muestra de estudiantes mexicanos de educación media. Rev Panam Salud Pública 2008;24(4):223-232.

  26. Sánchez H, Guisa V, Ortiz R, de Leó G. Detección temprana de factores de riesgo para el consumo de sustancias ilícitas. Salud Mental 2002;25(3):1-11.

  27. Secretaría de Salud. Encuesta Nacional de Adicciones 2008. México: Instituto Nacional de Salud Pública; 2008.

  28. Villatoro J, Gaytán F, Moreno M, Gutiérrez ML et al. Consumo de alcohol, tabaco y otras drogas en la ciudad de México. Medición 2009. México: Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz; 2010.

  29. Sistema de Información Epidemiológica del Consumo de Drogas. SIECD (2011). Consumo de drogas en pacientes de primer ingreso a tratamiento en Centros de Integración Juvenil, enero–junio de 2010. México: Centros de Integración Juvenil; 2011.

  30. English DR, Hulse GK, Milne E, Holman CD. Maternal cannabis use and birth weight: A meta-analysis. Addiction 1997;92:1553-1560.

  31. Rivkin MJ, Davis PE, Lemaster JI, Cabral HJ. Volumetric MRI study of brain in children with intrauterine exposure to cocaine, alcohol, tobacco and marijuana. Pediatrics 2008;121:741-750.

  32. Campolongo P, Trezza V, Ratano P, Palmery M. Developmental consequences of perinatal cannabis exposure: behavioral, and neuroendocrine effects in adult roedents. Psychopharmacology 2011;214:5-15.

  33. Day N, Leech S, Goldschmidt L. The effects of prenatal marijuana exposure on delinquent behaviors are mediated by measures of neurocognitive functioning. Neurotoxicology Teratology 2011;1:129-136.

  34. McKay DR, Tennant CC. Is de grass greener? The link between cannabis and psychosis. Med J Aust 2000;172:284-286.

  35. Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet 2009;17:(9698):1383-1391.

  36. Andreasson S, Allebeck P, Engstrom A, Rydberg U. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet 1987;2:1483-1486.

  37. Zammit S, Allebeck P, Andreasson S, Lundberg I et al. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. Br Med J 2002;325:1199-1201.

  38. Bovasso GB. Cannabis abuse as a risk factor for depressive symptoms. Am J Psychiatry 2001;158:2033-2037.

  39. Rey J. Cannabis and mental health. Br Med J 2002;325: 1183-1184.

  40. Van Os J, Bak M, Hanssen M, Biji RV et al. Cannabis use and psychosis: A longitudinal population-based study. Am J Epidemiol 2002;156:319-327.

  41. Arsenault L, Cannon M, Poulton R, Murray R et al. Cannabis use in adolescent and risk for adult psychosis: longitudinal prospective study. Br MedJ 2002;325:1212-1213.

  42. Marihuana. Canada: Information for health care professionales; 2010.

  43. Aldington S, Williams M, Nowitz M, Weatherall M et al. Effects of cannabis on pulmonary structure, function and symptoms. Thorax 2007;62:1058-1063.

  44. Hancox RJ, Poulton R, Ely M, Welch D et al. Effects of cannabis on lung function: a population-based cohort study. Eur Respir J 2010;35:42-47.

  45. Aldington S, Harwood M, Cox B, Weatherall M et al. Cannabis use and risk of lung cancer: a case-control study. Eur Respir J 2008;31:280-286.

  46. Armentia A, Castrodeza J, Ruiz-Muñoz P, Martínez-Quesada J et al. Allergic hypersensitivity to cannabis in patients with allergy and illicit drug users. Allergol Immunopathol (Madr) 2011;39(5):271-279.

  47. Cho CM, Hirsch R, Johnstone S. General and oral health implications of cannabis use. Aust Dent J 2005;50:70-74.

  48. Versteeg PA, Slot DE, van der Velden U, van der Weijden GA. Effect of cannabis usage on the oral environment: a review. Int J Dent Hyg 2008;6:315-320.

  49. Zhang ZF, Morgenstern H, Spitz MR, Tashkin DP et al. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev 1999;8:1071-1078.

  50. Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet 2009;374(9698):1383-1391.

  51. Shamloul R, Bella AJ. Impact of cannabis use on male sexual health. J Sex Med 2011;8:971-975.

  52. National Institute on Drug Abuse (NIDA). Abuso de la marihuana. Disponible en línea: http://www.nida.nih.gov/ResearchReports/Marihuana/ default.html

  53. The Monitoring the Future study. Michigan: The University of Michigan; 2008.

  54. MacCoun R, Reuter P. Interpreting dutch cannabis policy: Reasoning by analogy in the legalization debate. Science 1997;278:47-52.

  55. Dolin B. National drug policy: The Netherlands. prepared for the senate special committee on illegal drugs. Law and Government Division; 2001.




2020     |     www.medigraphic.com